Protein transfection of intact microvessels specifically modulates vasoreactivity and permeability.
Precise regulation of microvascular tone and barrier function is essential for proper coronary perfusion and performance. Agonist-induced alterations in either or both of these functions ultimately lead to microcirculatory dysfunction and cardiac insufficiency. Two important pathways involved in regulating vasomotor response and barrier function are the activation of nitric oxide synthase (NOS) and upregulation of protein kinase C (PKC). To date, studies of these two signaling proteins have relied mainly on pharmacological approaches. Unfortunately, the specificity of various inhibitors can be cause for concern. In order to address this problem, a protein transfection technique we developed for cultured endothelial cells has been modified and applied to isolated, intact coronary microvessels. Our results from green fluorescent protein transfection in arterioles and venules showed that this procedure could be used to introduce proteins into the microvascular wall. By transfecting inhibitor peptides against NOS and PKC into coronary arterioles and venules, we have been able to determine the specific roles of these two enzymes in vasodilation and hyperpermeability responses.
Tinsley
J H
JH
Department of Surgery, Cardiovascular Research Institute, Texas A&M University System Health Science Center, Temple, Tex 76504, USA. jht@tamu.edu
Zawieja
D C
DC
Wu
M H
MH
Ustinova
E E
EE
Xu
W
W
Yuan
S Y
SY
D000818:Animals; D001160:Arterioles / Q000187:drug effects / Q000502:physiology; D001920:Bradykinin / Q000494:pharmacology; D002199:Capillary Permeability; D002478:Cells, Cultured; D003331:Coronary Vessels; D004730:Endothelium, Vascular / Q000502:physiology; D004791:Enzyme Inhibitors; D049452:Green Fluorescent Proteins; D008164:Luminescent Proteins / Q000235:genetics; D008833:Microcirculation / Q000187:drug effects / Q000502:physiology*; D018613:Microscopy, Confocal; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D052250:Nitric Oxide Synthase Type III; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*; D012701:Serotonin / Q000494:pharmacology; D013552:Swine; D014162:Transfection; D014664:Vasodilation; D014699:Venules / Q000187:drug effects / Q000502:physiology
D004791:Enzyme Inhibitors; D008164:Luminescent Proteins; D049452:Green Fluorescent Proteins; D009569:Nitric Oxide; D012701:Serotonin; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D011493:Protein Kinase C; D001920:Bradykinin